Lake Street Starts Kyntra Bio (KYNB) at Buy Sep 17, 2026 07:47AM
Oppenheimer Reiterates Outperform Rating on Kyntra Bio (KYNB) Sep 1, 2026 03:56AM
Oppenheimer says this biotech name offers an "attractive buying opportunity" Aug 17, 2026 12:00PM
Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c Aug 13, 2026 04:10PM
Oppenheimer Starts Kyntra Bio (KYNB) at Outperform, PT $35 Jul 6, 2026 04:14PM


Jun 11, 2026 04:06PM Kyntra Bio presents roxadustat data showing transfusion improvements in MDS
Jun 9, 2026 07:01AM Rodman & Renshaw Starts Kyntra Bio (KYNB) at Buy
Apr 10, 2026 12:55PM RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
Apr 9, 2026 04:14PM Kyntra Bio receives Nasdaq delisting notice for asset requirement